Sub-standard and fake malaria drugs are threatening to undo gains made in the fight against the disease, according to a new study published in The Lancet Infectious Diseases on Monday. Scientists from the National Institutes of Health found that 36 percent of anti-malarial drugs analyzed in Southeast Asia were fake, while a third of drugs in sub-Saharan Africa contained either too much or not enough of the active ingredient. The researchers warn that the counterfeit drugs are contributing to a rise in drug-resistant malaria strains. More than three billion people worldwide are at risk from the mosquito-borne disease, which kills around 650,000 people a year.
Read more at the New York Times
Support Outside Online
Our mission to inspire readers to get outside has never been more critical. In recent years, Outside Online has reported on groundbreaking research linking time in nature to improved mental and physical health, and we’ve kept you informed about the unprecedented threats to America’s public lands. Our rigorous coverage helps spark important debates about wellness and travel and adventure, and it provides readers an accessible gateway to new outdoor passions. Time outside is essential—and we can help you make the most of it. Making a financial contribution to Outside Online only takes a few minutes and will ensure we can continue supplying the trailblazing, informative journalism that readers like you depend on. We hope you’ll support us. Thank you.